Our company is focused on discovery and development of therapeutics targeting Cytochromes P450 (CYPs) – a superfamily of proteins widely distributed in all kingdoms of life and involved in crucial biochemical pathways. 

In diversified pathological conditions a therapeutic effect can be achieved by modification of relevant CYP activity. 


Crystallography remains one of the most multidisciplinary sciences that links together frontier areas of research and has, directly or indirectly, produced the largest number of Nobel Laureates throughout history.

Protein crystallization is an intergal part of our R&D providing a basis for rational drug design.